Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase II study of avelumab in multiple relapsed/refractory germ cell cancer.AuthorsMego, M.; Svetlovska, D.; Chovanec, M.; Rečkova, M.; Rejlekova, K.; Obertova, J.; Palacka, P.; Sycova-Mila, Z.; De Giorgi, U.; Mardiak, J.PublicationInvestigational New Drugs, 2019, Vol 37, Issue 4, p748ISSN0167-6997Publication typeArticleDOI10.1007/s10637-019-00805-4